Hovione finishes $100M investment cycle for 200K SF manufacturing site

Hovione finalises $100m investment for East Windsor site expansion in US

Following expansion, the site will cover over 200,000ft² and feature new technologies in sustainably designed facilities. The initial phase of expansion comprises a 31,000ft² building that will accommodate The post Hovione finalises $100m investment for East Windsor site expansion in US appeared first on Pharmaceutical Business review.

Hovione invests $100M to expand East Windsor manufacturing

The basics: Hovione completes initial phase of $100M US expansion in East Windsor More than doubles spray drying capacity for drug development 31,000-sf facility includes two size-3 spray dryers; GMP operations begin Q2 2026 Future 125,000-sf greenfield site will add advanced pharma technologies Hovione, a global contract development and manufacturing organization, has completed the initial phase of a $100 million investment cycle to expand U.S…

Hovione finishes $100M investment cycle for 200K SF manufacturing site

Hovione, a fully integrated global CDMO, announced Oct. 27 the completion of an initial multimillion-dollar investment cycle to expand its manufacturing site in East Windsor. Upon completion, this campus will cover over 200,000 square feet, integrating the latest technologies within sustainably designed facilities. The initiative advances Hovione’s long-term strategy to grow its U.S. operations and enhance its integrated drug substance, drug pro…